Hypothalamic and Pituitary Hormone Drugs Flashcards
1
Q
- circulating endogenous growth hormone lasts _____ minutes
- recombinant growth hormone peaks at 2 to 4 hours and persists for ____ hours
A
25
36
2
Q
-GH promotes longitudinal bone growth until _______ closure
A
epiphyseal
3
Q
- primary growth hormone insufficiency characterized by severe postnatal growth failure
- caused by homozygous or compound heterozygous mutations in the GH receptor gene
- affect extracellular GH binding region of receptor
- Ecuador
- increased circulating levels of GH, low IGF-1 and IGFBP-3 levels
- tx: mecasermin (recombinant IGF-1)
- side effect is hypoglycemia, give with meal
A
Laron dwarfism
4
Q
- deletion of genes on paternal copy of chromosome 15, associated with growth failure, obesity, and carbohydrate intolerance
- GH replacement decreases body fat, increases lean body mass
A
Prader-Willi syndrome
5
Q
- 45X karyotype with mosaicism
- GH must be used to achieve max height
A
Turner syndrome
6
Q
- recombinant human IGF-1
- causes hypoglycemia, take carb containing meal 20 min before medication
A
mecasermin
7
Q
- large hands and feet, frontal bossing, coarse facial features
- carb intolerance, LVH, hypertension, colon polyps, GI malignancy
- dx: with somatomedin C (IGF-1), confirm with postprandial growth hormone
- transphenoidal surgery is primary treatment, octreotide normalizes GH
A
acromegaly
8
Q
- ischemic necrosis in an enlarging adenoma
- compression of superior hypophyseal artery against sellar diaphragm
- hemorrhage into the necrotic area
- rapid enlargmement and edema, acute pain, cranial nerve palsies, pituitary insufficiency
A
pituitary apoplexy
9
Q
- needs to be taken in empty stomach, should be taken an hour away from food
- calcium and iron supplements bind to medication and decrease absorption
A
levothyroxine
10
Q
contraindications to ______ therapy:
- young men who wish to bear children should not be placed on exogenous, which will lower sperm count and decrease testicular size
- known prostate or breast cancer
- untreated sleep apnea
- erythrocytosis
- urinary obstruction
A
testosterone
11
Q
dopamine receptor agonists, more selective for D2 receptor,lower prolactin secretion
A
cabergoline
12
Q
inhibit spontaneous and TRH induced release of prolactin, used to treat small prolactinoma, adverse n/v/headache/postural hypotension
A
bromocriptine
13
Q
- responsible for regulating body’s retention of water by increasing water absorption in collecting ducts of renal nephron, increases peripheral vascular resistance, which increases arterial blood pressures
- stimulators of vasopressin release: increased osmolarity, decrease in BP
A
vasopressin